3rd Quarter - Termination
CLARK HILL PUBLIC STRATEGIES LLC for WEST PHARMACEUTICAL SERVICES, INC.
Income
$20,000
Expenses
—
Terminated
Jul 31, 2026
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Matters relating to the pharmaceutical manufacturing and supply chain security.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA ALEKSANYAN | — |
| ANTHONY CAMPAU | Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team. |
| L. J. CHAVIS New | Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17). |
| CONRAD FURLICH | — |
Tariff (miscellaneous tariff bills) TAR
Matters relating to the pharmaceutical manufacturing and supply chain security.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA ALEKSANYAN | — |
| ANTHONY CAMPAU | Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team. |
| L. J. CHAVIS New | Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17). |
| CONRAD FURLICH | — |
Trade (domestic/foreign) TRD
Matters relating to the pharmaceutical manufacturing and supply chain security.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA ALEKSANYAN | — |
| ANTHONY CAMPAU | Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team. |
| L. J. CHAVIS New | Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17). |
| CONRAD FURLICH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.